AT THE FOREFRONT OF 

CRISPR THERAPEUTICS DEVELOPMENT

OUR TECHNOLOGY

Directly addressing the inherent limitations of current CRISPR methodologies, our technology seeks to unlock previously unattainable avenues in the development of CRISPR based therapeutics.

TECHNOLOGICAL FEATURES

Unprecedented

Homology-Directed

Repair Rates

Accounts for

Immunogenicity

Unique

RNP Delivery

Validated 

CRISPR Nuclease

"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
 

PROF. GEORGE CHURCH, CRISPR PIONEER

FIND OUT MORE.I

CONTACT US.

AddressIn

Institut NEOMED

7171 Frederick Banting
Saint-Laurent  H4S 1Z9

(Québec) Canada

Email

laurent.ziri@jenthera.com

 

    ©2020 Jenthera Therapeutics.  All Rights Reserved.